Form D — Glucose Health, Inc.
0001420108-26-000002 · filed Jul 7, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Manufacturing filings
Offering
- Industry
- Manufacturing
- Exemptions
- 06b
- Reported offering amount
- $120,000
- Reported amount sold
- $60,000
- Minimum investment
- $60,000
- Investors
- 1
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Glucose Health, Inc.
- CIK
- 1420108
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 609 SW 8TH STREET, SUITE 600
BENTONVILLE, AR 72712 - Phone
- 479-802-3827
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Mark Schaftlein · DirectorBentonville, AR Find on LinkedIn ↗
-
Marc Hatch · Executive OfficerBentonville, AR Find on LinkedIn ↗
-
Chris Jemapete · DirectorBentonville, AR Find on LinkedIn ↗
-
Edmund Burke · DirectorBentonville, AR Find on LinkedIn ↗
Other filings from this issuer
- Form D — Oct 19, 2026 — 0001420108-26-000007
- Form D — Oct 7, 2026 — 0001420108-26-000006
- Form D — Oct 6, 2026 — 0001420108-26-000005
- Form D — Oct 6, 2026 — 0001420108-26-000004
- Form D — Sep 10, 2026 — 0001420108-26-000003
- Form D — Feb 4, 2026 — 0001420108-26-000001
- Form D — Dec 5, 2025 — 0001420108-25-000002
View the original filing on SEC EDGAR ↗